-
Mashup Score: 10Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial - 2 day(s) ago
AbstractBackground and aims. Data describing the long-term efficacy, safety, and tolerability of inclisiran are limited. This was explored in ORION-8, an o
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 46
AbstractBackgroundThe glucagon-like peptide-1 receptor agonist, semaglutide, improved health status and reduced body weight in patients with obesity-related heart failure (HF) with preserved ejecti…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 46
AbstractBackgroundThe glucagon-like peptide-1 receptor agonist, semaglutide, improved health status and reduced body weight in patients with obesity-related heart failure (HF) with preserved ejecti…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 91
AbstractAimThe “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypert…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 91Initiation of Statins for Primary Prevention in Heart Failure With Preserved Ejection Fraction: - 24 day(s) ago
AbstractBackgroundStatins are highly effective for primary prevention of atherosclerotic cardiovascular disease (ASCVD) and mortality. Data on the benefit of statins in adults with heart failure wi…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 29Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort: - 1 month(s) ago
AbstractBackgroundLipoprotein(a) (Lp[a]) is a causal genetic risk factor for atherosclerotic cardiovascular disease (ASCVD). There are limited long-term follow-up data from large U.S. population co…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 29Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort: - 1 month(s) ago
AbstractBackgroundLipoprotein(a) (Lp[a]) is a causal genetic risk factor for atherosclerotic cardiovascular disease (ASCVD). There are limited long-term follow-up data from large U.S. population co…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 28
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 23
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial - 2 month(s) ago
AbstractBackgroundAlthough beta-blockers are not recommended for the treatment of heart failure with preserved ejection fraction (HFpEF) according to the latest European Society of Cardiology and A…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
ORION-8: extensión de seguimiento del tratamiento con inclisirán @ESC_Journals ☑️ Media seguimiento 3,7 años (máxima 6,8 años). ☑️ Reducción sostenida de c-LDL sin atenuación en su eficacia. ⬇️ media de c-LDL del 49%. https://t.co/MkuS3dn3r4 https://t.co/rw2QG2ZDil